Kirkland & Ellis advised TA Associates, a leading global growth private equity firm, on the sale of a majority interest in Aldevron to EQT Partners. TA Associates along with founders and management will retain a minority stake in Aldevron. Aldevron is the leading global supplier of GMP, GMP-SourceTM and Research Grade plasmid DNA used in commercial, clinical and research stage gene therapies, as well as proteins, antibodies and mRNA. Financial terms of the transaction were not disclosed. The transaction is expected to close by year-end, subject to customary regulatory approvals.
The Kirkland team was led by transactional partners Sean Kramer, Shelly Hirschtritt and Jeff Seifman; tax partners Vincent Thorn and Russell Light; and debt finance partners Brian Ford and Christopher Kirkham.